Literature DB >> 11885708

Transcatheter patent ductus arteriosus occlusion: evolution of techniques and results from the 1990s.

C O'Donnell1, J M Neutze, J R Skinner, N J Wilson.   

Abstract

OBJECTIVE: To review the evolution of transcatheter patent ductus arteriosus (PDA) occlusion techniques and results.
METHODS: A single institution, retrospective review including all patients with intention to close a PDA from 1991 to 1998, with no exclusions.
RESULTS: Rashkind occluder (n = 65), sideris double-button (n = 6), Cook detachable coil (n = 28) and Amplatzer ductal occluder (n = 4) were used. Successful implantation occurred in 99 of 103 patients. There was a need for a second transcatheter procedure to close residual ductal shunting in 12% of patients: Rashkind umbrellas (n = 8), double-button (n = 1), coils (n = 3). Eight patients (8%) required surgery, including 4 of 6 patients with the double-button occluder.
CONCLUSIONS: The Rashkind occluder and the Sideris double-button device both had an unacceptably high rate of residual shunts requiring a second transcatheter procedure or surgical closure. Detachable coils and the Amplatzer ductal occluder have become the current technology of choice for transcatheter PDA closure with high success rates.

Entities:  

Mesh:

Year:  2001        PMID: 11885708     DOI: 10.1046/j.1440-1754.2001.00689.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  2 in total

1.  Percutanous closure of patent ductus arteriosus in small infants of less than 8 kg body weight using different devices.

Authors:  Walter Knirsch; Nikolaus A Haas; Martin A G Lewin; Ingo Dähnert; Deniz Kececioglu; Felix Berger; Frank Uhlemann
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

2.  The results of transcatheter occlusion of patent ductus arteriosus: success rate and complications over 12 years in a single center.

Authors:  Deok Young Choi; Na Yeon Kim; Mi Jin Jung; Seong Ho Kim
Journal:  Korean Circ J       Date:  2010-05-27       Impact factor: 3.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.